We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$49.9B
AUM Growth
+$585M
Cap. Flow
-$2.78B
Cap. Flow %
-5.57%
Top 10 Hldgs %
36.03%
Holding
1,025
New
73
Increased
356
Reduced
366
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 24.25%
2 Healthcare 15.8%
3 Consumer Discretionary 14.05%
4 Communication Services 13.59%
5 Financials 12.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UAA icon
101
Under Armour
UAA
$2.6B
$52.9M 0.11%
5,206,438
-387,153
-7% -$3.35M
PJT icon
102
PJT Partners
PJT
$4.38B
$52.5M 0.11%
712,147
-17,033
-2% -$1.28M
HRI icon
103
Herc Holdings
HRI
$5.61B
$51.3M 0.1%
389,525
-22,413
-5% -$2.75M
XNCR icon
104
Xencor
XNCR
$1.55B
$50.6M 0.1%
1,943,451
+156,098
+9% +$4.37M
ABCB icon
105
Ameris Bancorp
ABCB
$5.89B
$50.1M 0.1%
1,063,403
-30,530
-3% -$1.53M
CNXC icon
106
Concentrix
CNXC
$1.57B
$49.3M 0.1%
370,080
+32,241
+10% +$3.92M
ACA icon
107
Arcosa
ACA
$7.11B
$49.2M 0.1%
904,596
+166,140
+22% +$9.87M
ENSG icon
108
The Ensign Group
ENSG
$10.7B
$49M 0.1%
517,750
-12,382
-2% -$1.12M
IR icon
109
Ingersoll Rand
IR
$33.7B
$48.4M 0.1%
925,619
-12,665
-1% -$647K
CRSP icon
110
CRISPR Therapeutics
CRSP
$5.17B
$48.3M 0.1%
1,188,321
-56,878
-5% -$3.02M
MSCI icon
111
MSCI
MSCI
$40.9B
$48.1M 0.1%
103,417
-3,239
-3% -$1.51M
DRVN icon
112
Driven Brands
DRVN
$2.2B
$47.9M 0.1%
1,753,313
-24,733
-1% -$740K
NOVT icon
113
Novanta
NOVT
$6.29B
$47.3M 0.09%
348,283
-8,328
-2% -$1.17M
AXON
114
Axon Enterprise
AXON
$46.4B
$47.3M 0.09%
284,756
+24,535
+9% +$3.88M
PTCT icon
115
PTC Therapeutics
PTCT
$6.12B
$46.8M 0.09%
1,226,265
-392,629
-24% -$16.3M
HEI icon
116
HEICO Corp
HEI
$51.4B
$46.6M 0.09%
303,578
+1,766
+0.6% +$275K
WEX icon
117
WEX
WEX
$6.31B
$46.6M 0.09%
284,557
+30,762
+12% +$4.79M
VEEV icon
118
Veeva Systems
VEEV
$37.4B
$45.8M 0.09%
283,790
-13,100
-4% -$2.24M
AIT icon
119
Applied Industrial Technologies
AIT
$13.3B
$45.3M 0.09%
359,624
-8,602
-2% -$1.06M
BJ icon
120
BJs Wholesale Club
BJ
$12.3B
$44.5M 0.09%
672,593
+4,373
+0.7% +$317K
TCOM icon
121
Trip.com Group
TCOM
$29.1B
$43.5M 0.09%
1,265,044
-43,621
-3% -$1.25M
TBBK icon
122
The Bancorp
TBBK
$2.84B
$43M 0.09%
1,514,922
-36,233
-2% -$1M
CALY
123
Callaway Golf Company
CALY
$3.14B
$41.5M 0.08%
2,101,500
+427,742
+26% +$8.43M
ACM icon
124
Aecom
ACM
$9.75B
$41.3M 0.08%
485,749
-149,798
-24% -$11.8M
DECK icon
125
Deckers Outdoor
DECK
$13.3B
$41.1M 0.08%
617,340
+62,070
+11% +$3.76M

Similar funds

Loomis, Sayles & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Loomis, Sayles & Company held 1,025 positions worth $49.9B, up 1.2% from $49.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Loomis, Sayles & Company withdrew a net $2.78B in Q4 2022, closing 173 positions and reducing 366 holdings. Its most notable exit was TechTarget, an estimated $41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in Zions Bancorporation worth $70.7M.

  • Loomis, Sayles & Company's largest Q4 2022 buy was Zions Bancorporation: 1,438,015 shares worth $70.7M.
  • Loomis, Sayles & Company added most to Tesla in Q4 2022, an estimated $644M increase.
  • Loomis, Sayles & Company's biggest Q4 2022 reduction was Deere & Co, cutting an estimated $435M.
  • Loomis, Sayles & Company fully exited TechTarget in Q4 2022, selling an estimated $41M.
  • Loomis, Sayles & Company's ten largest holdings make up 36% of its $49.9B portfolio in Q4 2022.
  • Loomis, Sayles & Company opened 73 new positions and closed 173 in Q4 2022.
  • Loomis, Sayles & Company's portfolio value rose 1.2% quarter-over-quarter to $49.9B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2022, filed 10 Feb 2023.